Noonan syndrome and Turner syndrome patients respond similarly to 4 years’ growth-hormone therapy: longitudinal analysis of growth-hormone-naïve patients enrolled in the NordiNet® International Outcome Study and the ANSWER Program
Main Authors: | Lee, Peter A., Ross, Judith L., Pedersen, Birgitte Tønnes, Kotnik, Primoz, Germak, John A., Christesen, Henrik T. |
---|---|
Format: | Online |
Language: | English |
Published: |
BioMed Central
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562101/ |
Similar Items
-
The NordiNet® International Outcome Study and NovoNet® ANSWER Program®: rationale, design, and methodology of two international pharmacoepidemiological registry-based studies monitoring long-term clinical and safety outcomes of growth hormone therapy (Norditropin®)
by: Höybye, Charlotte, et al.
Published: (2013) -
Effect of 4 years of growth hormone therapy in children with Noonan syndrome in the American Norditropin Studies: Web-Enabled Research (ANSWER) Program® registry
by: Lee, Peter A, et al.
Published: (2012) -
The other side of Turner's: Noonan's syndrome
by: Agarwal, Pankaj, et al.
Published: (2013) -
Concomitant occurrence of Turner syndrome and growth hormone deficiency
by: Yu, Jung, et al.
Published: (2016) -
Growth Hormone Deficiency in a Child with Neurofibromatosis-Noonan Syndrome
by: Vurallı, Doğuş, et al.
Published: (2016)